Comparative Study That Evaluates the Effectiveness of Intradermotherapy with 0.5% Minoxidil Versus Topical Application of 5% Monoxidil Solution in the Treatment of Androgenetic Alopecia

Journal Title: Journal of Dermatology Research - Year 2025, Vol 6, Issue 1

Abstract

Introduction: Androgenetic alopecia is the most common cause of hair loss, progressively affecting both men and women and causing great impact on quality of life. Among many possible treatments, intradermotherapy is a promising and controversial procedure, with few studies in the literature so far. Objectives: Comparatively evaluate the efficacy of intradermotherapy with a 5% minoxidil solution in patients with androgenetic alopecia. Methods: Patients were randomly divided into two groups. Group 1, with 13 participants, went through 10 sessions of intradermotherapy with 7 day intervals between each one. Group 2, with 11 participants, applied 1 ml of a topical minoxidil 5% solution on dry scalp twice a day throughout this study. All patients were evaluated with clinical and trichoscopic pictures taken before and after 12 weeks of treatment. Results: Most patients in both groups perceived improved capillary density and thickness of hair strands, and reduced hair loss, without statistical difference between group 1 and 2. Trichoscopic evaluation performed by specialists did not find statistical difference between the groups. Conclusion: The results of intradermotherapy with minoxidil are similar to the results of topical application of the same substance.

Authors and Affiliations

Priscila Regina Orso Rebellato1*, Carolina Labigalini Sampaio2, Giovana Liz Marioto de Campos1, Adriane Costa3, Andrea Buosi Fabre4, Juliano Vilaverde Schmitt5

Keywords

Related Articles

Cutaneous Drug Eruption after COVID-19 Vaccination

The SARS-CoV-2 virus is a highly transmissible virus that has infected millions of people globally over the past year. In the United States alone, over 400,000 deaths have been reported due to COVID-19 infection [1]. I...

Stem Cell Therapy in Androgenetic Alopecia: A Review of Dermatology Literature from 2012-2022

Androgenetic alopecia is considered the most frequent form of progressive hair loss. In this disease, an alteration of the hair cycle dynamics leads to progressive miniaturization of the hair follicle and possible baldne...

The Efficacy and Safety of Oral Propranolol in Hemangioma of PHACES Syndrome: A Case Report

PHACES syndrome is a rare condition characterized by the association of infantile hemangioma with malformations of the posterior fossa of the brain, arterial anomalies of the central nervous system, heart defects, ocular...

The Prevalence of Dermatoses Among Resident Doctors and Medical Students During COVID-19 Pandemic: A Cross-Sectional Study

Objectives: To verify the prevalence of dermatoses in resident doctors during the period recruited for the COVID-19 pandemic and also compare it to medical students. Methods: Cross-sectional study using a convenience...

Facial Demodicidosis Revealing HIV

Demodecidosis is an opportunistic cutaneous ectoparasitosis, common to humans and many mammals, caused by the proliferation of Demodex in the pilosebaceous apparatus. This obligate saprophyte of the skin, ostia-pilosebac...

Download PDF file
  • EP ID EP758355
  • DOI https://doi.org/10.46889/JDR.2025.6103
  • Views 39
  • Downloads 0

How To Cite

Priscila Regina Orso Rebellato1*, Carolina Labigalini Sampaio2, Giovana Liz Marioto de Campos1, Adriane Costa3, Andrea Buosi Fabre4, Juliano Vilaverde Schmitt5 (2025). Comparative Study That Evaluates the Effectiveness of Intradermotherapy with 0.5% Minoxidil Versus Topical Application of 5% Monoxidil Solution in the Treatment of Androgenetic Alopecia. Journal of Dermatology Research, 6(1), -. https://europub.co.uk/articles/-A-758355